HAZLETT, BURT & WATSON, INC.

Position in CRSP — CRISPR Therapeutics AG

CIK 46392 WHEELING, WV

Position in CRSP

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$327

+$42 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#497

of 519 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HAZLETT, BURT & WATSON, INC. holds $93,894 across 5 Biotechnology names. CRSP ranks #5 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FTRE	Fortrea Holdings Inc.	4,672	$81,292
2	REGN	Regeneron Pharmaceuticals, Inc.	14	$8,729
3	HALO	Halozyme Therapeutics, Inc.	40	$3,130
4	IOVA	Iovance Biotherapeutics, Inc.	100	$416
5	CRSP	CRISPR Therapeutics AG This page	6	$327

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$327	6	0.0%	Shares	Sole	2026-07-30
2026-03-31	$285	6	0.0%	Shares	Sole	2026-05-14
2025-12-31	$314	6	0.0%	Shares	Sole	2026-02-10
2025-09-30	$388	6	0.0%	Shares	Sole	2025-11-04
2025-06-30	$291	6	0.0%	Shares	Sole	2025-07-25
2025-03-31	$204	6	0.0%	Shares	Sole	2025-05-05
2024-12-31	$236	6	0.0%	Shares	Sole	2025-02-12
2024-09-30	$281	6	0.0%	Shares	Sole	2024-10-30
2024-06-30	$324	6	0.0%	Shares	Sole	2024-08-07
2024-03-31	$408	6	0.0%	Shares	Sole	2024-04-29
2023-12-31	$375	6	-93.2%	Shares	Sole	2024-01-25
2023-09-30	$3,993	88	—	Shares	Sole	2023-11-02
No filing history on record for this holder in this stock.